Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor α transcriptional activity

Molecular Biology of the Cell

Volumn 17, Issue 4, 2006, Pages 1822-1833

  Liu, Guang Hui ^a   Qu, Jing ^a   Shen, Xun ^a,b  

^a INSTITUTE OF BIOPHYSICS   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CARNITINE PALMITOYLTRANSFERASE; DNA; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RNA; THIOREDOXIN; THIOREDOXIN REDUCTASE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ELECTROPHORETIC MOBILITY; GENE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NEGATIVE FEEDBACK; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CULTURE; CELL NUCLEUS; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; GEL MOBILITY SHIFT ASSAY; GENETICS; HOMEOSTASIS; METABOLISM; PROTEIN ANALYSIS; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; TWO HYBRID SYSTEM;

MAMMALIA;

CELL NUCLEUS; CELLS, CULTURED; DNA; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HOMEOSTASIS; HUMANS; PPAR ALPHA; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RESPONSE ELEMENTS; THIOREDOXIN; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33745396325     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E05-10-0979     Document Type: Article

References (53)

1. Akiyama, T. E., Baumann, C. T., Sakai, S., Hager, G. L., and Gonzalez, F. J. (2002). Selective intranuclear redistribution of PPAR isoforms by RXR alpha. Mol. Endocrinol. 26, 707-721.
2. Bai, J., Nakamura, H., Kwon, Y. W., Hattori, I., Yamaguchi, Y., Kim, Y. C., Kondo, N., Oka, S., Ueda, S., Masutani, H., and Yodoi, J. (2003). Critical roles of thioredoxin in nerve growth factor-mediated signal transduction and neurite outgrowth in PC12 cells. J. Neurosci. 23, 503-509.
3. Blanquart, C., Barbier, O., Fruchart, J. C., Staels, B., and Glineur, C. (2002). Peroxisorrve proliferator-activated receptor alpha (PPAR alpha) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes. J. Biol. Chem. 277, 37254-37259.
4. Bloomfield, K. L., Osborne, S. A., Kennedy, D. D., Clarke, F. M., and Tonissen, K. F. (2003). Thioredoxin-mediated redox control of the transcription factor SpI and regulation of the thioredoxin gene promoter. Gene 339, 107-116.
5. Bodnar, J. S. et al. (2002). Positional cloning of the combined hyperlipidemia gene Hyplipl. Nat. Genet. 30, 110-116.
6. Cabrero, A., Alegret, M., Sanchez, R. M., Adzet, T., Laguna, J. C., and Carrera, M. V. (2002). Increased reactive oxygen species production down-regulates peroxisome proliferator-activated a pathway in C2C12 skeletal muscle cells. J. Biol. Chem. 277, 10100-10107.
7. Chatterjee, S., and Stochaj, U. (1998). Diffusion of proteins across the nuclear envelope of HeLa cells. Biotechniques 24, 668-674.
8. Chen, K., Li, D., Zhang, X., Hermonat, P. L., and Mehta, J. L. (2004). Anoxiareoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J. Cardiovasc. Pharmacol. 44, 682-687.
9. Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J. C., Tedgui, A., Haegeman, G., and Staels, B. (1999). Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274, 32048-32054.
10. Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., and Leid, M. (1997). p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 272, 33435-33443.
11. Dowell, P., Ishmael, J. E., Avram, D., Peterson, V. J., Nevrivy, D. J., and Leid, M. (1999). Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein. J. Biol. Chem. 274, 15901-15907.
12. Drori, S., Girnun, G. D., Tou, L., Szwaya, J. D., Mueller, E., Xia, K., Shivdasani, R. A., and Spiegelman, B. M. (2005). Hic-5 regulates an epithelial program mediated by PPARgamma. Genes Dev. 29, 362-375.
13. Evans, R. M., Barish, G. D., and Wang, Y. X. (2004). PPARs and the complex journey to obesity. Nat. Med. 20, 355-361.
14. Feige, J. N., Gelman, L., Tudor, C., Engelborghs, Y., Wahli, W., and Desvergne, B. (2005). Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J. Biol. Chem. 280, 17880-17890.
15. Girnun, G., Domann, F. E., Moore, S. A., and Robbins, M.E.C. (2002). Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol. Endocrinol. 16, 2793-2801.
16. Gulick, T., Cresci, S., Caira, T., Moore, D. D., and Kelly, D. P. (1994). The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc. Natl. Acad. Sci. USA 91, 11012-11016.
17. Hayashi, S., Hajiro-Nakanishi, K., Makino, Y., Eguchi, H., Yodoi, J., and Tanaka, H. (1997). Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 25,4035-4040.
18. Hirota, K., Murata, M., Sachi, Y., Nakamura, H., Takeuchi, J., Mon, K., and Yodoi, J. (1999). Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 274, 27891-27897.
19. Holmgren, A. (1985). Thioredoxin. Annul. Rev. Biochem. 54, 237-271.
20. Hsu, M. H., Savas, U., Griffin, K. J., and Johnson, E. F. (2001). Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells. J. Biol. Chem. 276, 27950-27958.
21. Hwang, C. Y., Ryu, Y. S., Chung, M. S., Kim, K. D., Park, S. S., Chae, S. K., Chae, H. Z., and Kwon, K. S. (2004). Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jabl. Oncogene 23, 8868-8875.
22. Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A., and Desvergne, B. (1997). DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region. J. Biol. Chem. 272, 25252-25259.
23. Juge-Aubry, C. E., Hammar, E., Siegrist-Kaiser, C., Pernin, A., Takeshita, A., Chin, W. W., Burger, A. G., and Meier, C. A. (1999). Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274, 10505-10510.
24. Juge-Aubry, C. E., Kuenzli, S., Sanchez, J. C., Hochstrasser, D., and Meier, C. A. (2001). Peroxisomal bifunctional enzyme binds and activates the activation function-1 region of the peroxisome proliferator-activated receptor alpha. Biochem. J. 353, 253-258.
25. Junn, E. et al. (2000). Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 364, 6287-6295.
26. Karimpour, S. et al. (2002). Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene 21, 6317-6327.
27. Karin, M., and Greten, F. R. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759.
28. Kerley, J. S., Olsen, S. L., Freemantle, S. J., and Spinella, M. J. (2001). Transcriptional activation of the nuclear receptor corepressor RIP140 by retinoic acid: a potential negative-feedback regulatory mechanism. Biochem. Biophys. Res. Commun. 285, 969-975.
29. Von Knethen, A., and Bruene, B. (2002). Activation of peroxisome proliferator-activated receptor a by nitric oxide in monocytes/macrophages downregulates p47phox and attenuates the respiratory burst. J. Immunol. 369, 2619-2626.
30. Lemberger, T., Desvergne, B., and Wahli, W. (1996). Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell. Dev. Biol. 22, 335-363.
31. Makino, Y., Yoshikawa, N., Okamoto, K., Hirota, K., Yodoi, J., Makino, I., and Tanaka, H. (1999). Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem. 274, 3182-3188.
32. Meertens, L. M., Miyata, K. S., Cechetto, J. D., Rachubinski, R. A., and Capone, J. P. (1998). A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha. EMBO J. 27, 6972-6978.
33. Mochizuki, K., Suruga, K., Sakaguchi, N., Takase, S., and Goda, T. (2002). Major intestinal coactivator p300 strongly activates peroxisome proliferator-activated receptor in intestinal cell line, Caco-2. Gene 292, 271-277.
34. Morishima, A., Ohkubo, N., Maeda, N., Miki, T., and Mitsuda, N. (2003). NFκB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha. J. Biol. Chem. 278, 38188-38193.
35. Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., and Johnson, E. F. (1998). Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol. 53, 14-22.
36. Pawliczak, R., Han, C., Huang, X. L., Demetris, A. J., Shelhamer, J. H., and Wu, T. (2002). 85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells. J. Biol. Chem. 277, 33153-33163.
37. Powis, G., and Montfort, W. R. (2001). Properties and biological activities of thioredoxins. Annu. Rev. Pharmacol. Toxicol, 42, 261-295.
38. Rival, Y., Beneteau, N., Taillandier, T., Pezet, M., Dupont-Passelaigue, E., Patoiseau, J. F., Junquero, D., Colpaert, F. C., and Delhon, A. (2002). PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells. Eur. J. Pharmacol. 435, 143-151.
39. Sakurai, A., Yuasa, K., Shoji, Y., Himeno, S., Tsujimoto, M., Kunimoto, M., Imura, N., and Hara, S. (2004). Overexpression of thioredoxin reductase 1 regulates NF-kappa B activation. J. Cell. Physiol. 298, 22-30.
40. Sasada, T., Iwata, S., Sato, N., Kitaoka, Y., Hirota, K., Nakamura, K., Nishiyama, A., Taniguchi, Y., Takabayashi, A., and Yodoi, J. (1996). Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxidty. J. Clin. Invest. 97, 2268-2276.
41. Schulze, P. C., De Keulenaer, G. W., Yoshioka, J., Kassik, K. A., and Lee, R. T. (2002). Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ. Res. 92, 689-695.
42. Schulze, P. C., Yoshioka, J., Takahashi, T., He, Z., King, G. L., and Lee, R. T. (2004). Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J. Biol. Chem. 279, 30369-30374.
43. Stier, H., Fahimi, H. D., Van Veldhoven, P. P., Mannaerts, G. P., Volkl, A., and Baumgart, E. (1998). Maturation of peroxisomes in differentiating human hepatoblastoma cells (HepG2): possible involvement of the peroxisome proliferator-activated receptor alpha (PPAR alpha). Differentiation 64, 55-66.
44. Teissier, E., Nohara, A., Chinetti, G., Paumelle, R., Cariou, B., Fruchart, J. C., Brandes, R. P., Shah, A., and Staels, B. (2004). Peroxisome proliferator-activated receptor α induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-α activation properties. Circ. Res. 95, 1174-1182.
45. Thompson, C. C., and Bottcher, M. C. (1997). The product of a thyroid hormone-responsive gene interacts with thyroid hormone receptors. Proc. Natl. Acad. Sci. USA 94, 8527-8532.
46. Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., and Green, S. (1992) The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 22, 433-439.
47. Varanasi, U., Chu, R., Huang, Q., Castellon, R., Yeldandi, A. V., and Reddy, J. K. (1996). Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene. J. Biol. Chem. 271, 2147-2155.
48. Vega, R. B., Huss, J. M., and Kelly, D. P. (2000). The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell Biol. 20, 1868-1876.
49. Von Knethen, A., and Brune, B. (2002). Activation of peroxisome proliferator-activated receptor gamma by nitric oxide in monocytes/macrophages down-regulates p47phox and attenuates the respiratory burst. J. Immunol. 169, 2619-2626.
50. Watson, W. H., Yang, X., Choi, Y. E., Jones, D. P., and Kehrer, J. P. (2003). Thioredoxin and its role in toxicology. Toxicol. Sci. 78, 3-14.
51. Yoo, H. Y., Chang, M. S., and Rho, H. M. (1999). Induction of the rat Cu/Zn Superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234, 87-91.
52. Zheng, Y., Zhong, L., and Shen, X. (2005). Effect of selenium-supplement on the calcium signaling in human endothelial cells. J. Cell Physiol. 205, 97-106.
53. Zhou, Y. C., and Waxman, D. J. (1999). STAT5b down-regulates peroxisome proliferator-acrivated receptor alpha transcription by inhibition of ligand-independent activation function region-1 trans-activation domain. J. Biol. Chem. 274, 29874-29882.